JAFCO Group
VC Fund
JAFCO Group is a venture capital firm that primarily invests in domestic and foreign private companies.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries JAFCO Group invests in
Stages JAFCO Group invests in
Countries JAFCO Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series B
- $5.5M–$283M
- Series C
- $7.3M–$198M
Investment Focus
Industry
- Information Technology 8 (22%)
- E-Commerce 6 (16%)
- Software 5 (14%)
- Retail 4 (11%)
- Health Care 4 (11%)
Stage
- Series B 9 (24%)
- Funding Round 8 (22%)
- Series C 6 (16%)
- Seed 4 (11%)
- Venture - Series Unknown 3 (8%)
Country
- Japan 29 (78%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Fumito Takashima
Principal
|
Principal | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Parallel
|
Parallel is a virtual hangout platform that allows sharing content with friends. On the social networking site Parallel, users can enjoy a variety of content while chatting with their close friends. It enables the creation of a room where anyone who has been invited may enter and can immediately begin speaking. | $7.9M / Series C / Mar 19, 2024 | |
Blue Laser Fusion
|
Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor. | $37.5M / Seed / Mar 06, 2024 | |
Nanofiber Quantum Technologies
|
Nanofiber Quantum Technologies is a research and manufacturing company that develops hardware for quantum communications. Its technologies provide quantum computers using nanofibers and advanced engineering, specializing in quantum cryptography, quantum communications, and other technologies related to quantum science for social implementation. | $8.5M / Convertible Note / Sep 15, 2023 | |
|
Blue Laser Fusion
|
Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor. | $25M / Seed / Jul 27, 2023 | |
Wakaze
|
Wakaze is a supplier of craft sake beer. They provide products that include beer, other alcoholic beverages, food products, snacks, and drinks. They provide products that are available for online shopping. An online inquiry form is available on the company's website. | $7.7M / Series B / Jan 12, 2023 | |
Synspective
|
Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure humanactivity over a wide area on earth, regardless of time or weather. | $96.3M / Series B / Mar 28, 2022 | |
Alivexis
|
Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus iscomprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms. | $20.4M / Series C / Mar 01, 2022 | |
Kyoto Fusioneering
|
Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors. | $184.3M / Series B / Feb 02, 2022 | |
CADDi
|
CADDi is an online ordering platform for manufacturing industry. | $73M / Series B / Aug 23, 2021 | |
Molcure
|
Molcure is antibody and Peptide drug-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of patients by developing and providing more effective therapeutics and supportive care products. Molcure represents high quality antibody and target discovery. With cutting edge technology in-house, Molcure is thepartner of choice for therapeutic antibody discovery. At Molcure they combine a deep knowledge of NGS, bioinformatics and antibody biology with automated discovery system. The antibody discovery platform Abtracer delivers superior functional antibodies. Their technology is validated through a number of partnerships. They are seeking new partnership opportunities. | $7.3M / Series C / Aug 18, 2021 | |
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does JAFCO Group invest in?
JAFCO Group invests primarily in Information Technology, E-Commerce and Software startups, most often at Series B and Funding Round stage. Most of the 37 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is JAFCO Group's check size?
JAFCO Group typically joins rounds of $5.5M–$283M at Series B and $7.3M–$198M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds JAFCO Group participates in.
How do I contact JAFCO Group?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at JAFCO Group?
The team at JAFCO Group includes Fumito Takashima (Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
